investor.cvc-tech.com
皇將科技 - 投資人資訊版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
http://investor.cvc-tech.com/
版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
http://investor.cvc-tech.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
PAGES IN
THIS WEBSITE
7
SSL
EXTERNAL LINKS
0
SITE IP
0.0.0.0
LOAD TIME
0 sec
SCORE
6.2
皇將科技 - 投資人資訊 | investor.cvc-tech.com Reviews
https://investor.cvc-tech.com
版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
investor.cvc-tech.com
股價及股利資訊
http://investor.cvc-tech.com/StockPriceInfo.aspx
版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
投資人服務
http://investor.cvc-tech.com/president.html
皇將公司專注製藥設備生產線37年，養成了嚴謹，精密的企業文化，累積了厚實的根基 因此吸引了美國Micro-Tech Scientific, Inc. 加入皇將，讓皇將得以更進一步的往更高科技的檢驗儀器發展。 皇將知道檢驗儀器事業是一條艱辛的路，但只要股東們持續支持，勇往直前 我們自信這條路一定成功;何況生命科學、生技是未來明亮的產業，各國無不卯足勁發展 檢驗儀器與此息息相關，市場前景看好。 版權所有 皇將科技股份有限公司 ADD:台中縣大里市仁化路 361號 TEL: 886 4 24969922 FAX: 886 4 24969933.
投資人服務
http://investor.cvc-tech.com/InvestorServices.aspx
林靜美 - 行政副總 電話: 04-3705-6666 #812 Email: tiffany.lin@cvctechnologies.com. 陳翰儂 - 財務副理 電話: 04-3705-6666 #811 Email: shiny.chen@cvctechnologies.com. 版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
股東會資訊
http://investor.cvc-tech.com/ShareholderInfo.aspx
版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
公司治理
http://investor.cvc-tech.com/CorporateGovernance.aspx
版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
TOTAL PAGES IN THIS WEBSITE
7
Crescent Capital Partners
Grow Increase. Expand. Grow increase. expand. Sign On - Welcome to Crescent Capital Partners registered members site. Enter your email address below and we will email you your password?
Crown Castle: Investors
Outdoor Small Cell Solutions. Indoor Small Cell Solutions. Theme Parks and Recreation. Stadiums and Convention Centers. A stable model for future growth. View All Upcoming Events. Crown Castle Completes Acquisition of Sunesys. August 04, 2015. Crown Castle Declares Quarterly Common Stock Dividend. August 03, 2015. Crown Castle Reports Second Quarter 2015 Results and Raises Outlook for 2015. July 22, 2015. Crown Castle Announces Second Quarter 2015 Earnings Release and Conference Call Schedule.
Investors - CTG
CTG's strong healthcare IT business is the focus of our growth strategy. Current Annual Report and Proxy Material. CTG Reports 2015 Second Quarter Results. CTG Schedules 2015 Second Quarter Results Release, Conference Call and Webcast. CTG Announces Extension of 10b5-1 Plan to Facilitate Share Repurchases. View all news releases ». Aug 7, 2015 at 4:00 PM ET. Minimum 20 minutes delay. CTG Reports 2015 Second Quarter Results. Jul 28, 2015. Jul 15, 2015. Jul 8, 2015. Jul 28, 2015 at 8:30 AM ET.
ctnet.com - This website is for sale! - ctnet Resources and Information.
The domain ctnet.com. May be for sale by its owner! This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
Cummins.com > Disclaimer
Online Parts and Service. Annual Meeting / Proxy Materials. Disclosure Regarding Forward-Looking Statements:. I have read this disclaimer. 2014 Cummins Inc.,Box 3005, Columbus, IN 47202-3005 U.S.A.
皇將科技 - 投資人資訊
版權所有 皇將科技股份有限公司 ADD:台中市大里區工業九路190號 TEL: 886 4 3705-6666 FAX: 886 4 3705-6555.
Overview | Cyalume
Covering the EMEA Region. Where To Find Us. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyalumes financial performance into perspective. 2:26 PM ET on Sep 19, 2017. Delayed at least 20 minutes. Annual Reports and Proxies. Aug 8, 2017. Cyalume Technologies Holdings, Inc. to Be Acquired by an Affiliate of Arsenal Capital Partners. Cyalume Technologies, Inc. 910 SE 17th Street. 33 (0) 4 42 37 17 80.
Q4 Web Site Development
Q4 Web Maintenance Message. This site is currently under development and not yet available for public viewing. For more information on why this site is not available, please contact Q4.
Overview | Cyclacel Pharmaceuticals, Inc.
Skip to main navigation. Research and Development Pipeline. CYC116 Aurora Kinase and VEGFR2 Inhibitor. Cell Cycle in Cancer. Drug Discovery and Development Approach. Corporate Presentations and Events. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyclacel Pharmaceuticals, Inc.'s financial performance into perspective. Fourth Quarter and Full Year 2017 Financial Results. 30th Annual ROTH Conference.
China Yuchai International Limited (“CYI”) - Investor Relations - Investors Home
Q2 2015 China Yuchai International Limited Earnings Conference Call. 160;at 8:00 pm ET. Q2 2015 China Yuchai International Limited Earnings Conference Call. Tuesday, August 11, 2015 . 8:00 pm ET . Through Tuesday, August 11, 2015 . Click here for webcast. Click here to add this event to your calendar. CYI has also invested in HL Global Enterprises Limited ( HLGE ) which is listed on the main board of the Singapore Exchange. Currently, CYI holds 48.9% shareholding interest in HLGE. The core businesses of...
Cyxone » Investor relations
Cyxone är ett resurssnålt bolag. Cyxone är ett resurssnålt bolag fokuserat på att utveckla läkemedelskandidaten T20K mot Multipel Skleros (MS). T20K har passerat forskningsstadiet vilket kortar ner tiden till värdehöjande händelser som t.ex. kliniska studier. De egenskaper T20K visat i cell- och djurstudier har potential att utveckla substansen till en genombrottsprodukt för att behandla MS-patienter i olika sjukdomsstadier. VD Kjell Stenberg presenterar Cyxone på Stora Aktiedagen i Stockholm.
